Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), ...

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden in a nationwide cohort. Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in ...

Patients with breast cancer may be able to avoid lymphedema, which can occur after surgery to remove lymph nodes in the ...

Stanford spinout opens investment opportunity to support development of ultrafast radiation delivery technology ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

Episcopal Health Services announced on Tuesday, March 24, that it is now offering low-dose radiotherapy using its new ...

The treatment showed effectiveness in achieving local control of acute myeloid leukemia (AML) that developed in the eyes of a pediatric patient. When AML is present outside of the bone marrow and ...

In this episode of the NeuroOp Guru in collaboration with Ophthalmology Times, host Andrew G. Lee, MD, is joined by Drew Carey, MD, to discuss pretreatment features associated with vision improvement ...

Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising ...

Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001). This is an ASCO Meeting Abstract from the 2023 ...